Study on the Efficacy of Endoscopic Radiofrequency Treatment in Reducing the Need for Blood Transfusions in GAVE

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 2, 2025

Primary Completion Date

July 2, 2027

Study Completion Date

September 2, 2027

Conditions
GAVE - Gastric Antral Vascular Ectasia
Interventions
PROCEDURE

Endoscopic Radiofrequency treatment

Treatment with RFA will carried out with focal RFA with a TTS catheter at 12 Joule/cm2 to all visible areas of GAVE under conscious sedation or propofol sedation by experienced team of endoscopists and anesthetists

OTHER

QoL EQ5D questionaire

Quality of Life EQ5D (by EuroQol Group) before every RFA treatment and at Follow up visits (3, 6 and 12 months after the first procedure). QoL questionnaire EQ5D The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis

OTHER